THE FGFR3 MUTATION IS RELATED TO FAVORABLE PT1 BLADDER CANCER

被引：0
|
作者：
Van Rhijn, B. W. G. [1 ]
Bapat, B. [2 ]
Van Der Kwast, T. H. [3 ]
Liu, L. [2 ]
Fleshner, N. E. [1 ]
Van Der Aa, M. N. M. [4 ]
Vajpeyi, R. [1 ]
Bangma, C. H. [4 ]
Zwarthoff, E. C. [5 ]
Jewett, M. A. S. [1 ]
Zlotta, A. R. [1 ]
机构：
[1] Univ Toronto, Univ Hlth Network, Dept Surg Oncol Urol, Toronto, ON, Canada
[2] Univ Toronto, Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Dept Lab Med & Pathobiol, Toronto, ON M5G 1X5, Canada
[3] Univ Toronto, Univ Hlth Network, Dept Surg Pathol, Toronto, ON, Canada
[4] Erasmus MC, Dept Urol, Rotterdam, Netherlands
[5] Erasmus MC, Dept Pathol, Rotterdam, Netherlands
来源：
EUROPEAN UROLOGY SUPPLEMENTS | 2009年 / 8卷 / 04期
关键词：
D O I：
10.1016/S1569-9056(09)60313-4
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：197 / 197
页数：1
相关论文
共 50 条
  • [31] The FGFR3 Story in Bladder Cancer: Another Piece of the Puzzle?
    Flippot, Ronan
    Loriot, Yohann
    EUROPEAN UROLOGY, 2020, 78 (05) : 688 - 689
  • [32] FGFR3, TERT, TP53 mutations and the FGFR3 gene expression in bladder cancer as prognostic markers
    Mikhaylenko, D. S.
    Sergienko, S. A.
    Kuznetsova, E. B.
    Zaborsky, I. N.
    Martynov, M., I
    Loran, O. B.
    Efremov, G. D.
    Samoylova, S. A.
    Alekseev, B. Ya
    Musatova, V. V.
    Bure, I., V
    Nemtsova, M., V
    ONKOUROLOGIYA, 2021, 17 (01): : 89 - 100
  • [33] novel somatic FGFR3 mutation in primary lung cancer
    Shinmura, Kazuya
    Kato, Hisami
    Matsuura, Shun
    Inoue, Yusuke
    Igarashi, Hisaki
    Nagura, Kiyoko
    Nakamura, Satoki
    Maruyama, Kyoko
    Tajima, Mari
    Funai, Kazuhito
    Ogawa, Hiroshi
    Tanahashi, Masayuki
    Niwa, Hiroshi
    Sugimura, Haruhiko
    ONCOLOGY REPORTS, 2014, 31 (03) : 1219 - 1224
  • [34] AN FGFR3 MUTATION IN CELLS OBTAINED FROM VOIDED URINE IS A STRONG PREDICTOR OF RECURRENT BLADDER CANCER
    Zuiverloon, T. C. M.
    Van der Aa, M. N. M.
    Van Der Kwast, T. H.
    Steyerberg, E. W.
    Bangma, C. H.
    Zwarthoff, E. C.
    EUROPEAN UROLOGY SUPPLEMENTS, 2009, 8 (04) : 372 - 372
  • [35] Tumour heterogeneity and FGFR3 mutation detected in urinary sediment by digital PCR in bladder cancer patients
    Borkowska, E. M.
    Traczyk-Borszynska, M.
    Jablonowski, Z.
    Sosnowski, M.
    Borowiec, M.
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2018, 26 : 680 - 681
  • [36] An FGFR3 mutation in cells obtained from voided urine is a strong predictor of recurrent bladder cancer
    Zwarthoff, Ellen
    van der Aa, Madelon
    van der Kwast, Theo
    Steyerberg, Ewout
    Bangma, Chris
    Zuiverloon, Tahlita
    CANCER RESEARCH, 2009, 69
  • [37] Upregulation of FGFR3 and HIF-1α expression in muscle invasive bladder cancer
    Warli, Syah Mirsya
    Laksmi, Lidya Imelda
    Safriadi, Ferry
    Umbas, Rainy
    MEDICAL JOURNAL OF INDONESIA, 2019, 28 (01) : 3 - 7
  • [38] High CDKN2A/p16 and Low FGFR3 Expression Predict Progressive Potential of Stage pT1 Urothelial Bladder Carcinoma
    Breyer, Johannes
    Wirtz, Ralph M.
    Erben, Philipp
    Worst, Thomas S.
    Stoehr, Robert
    Eckstein, Markus
    Bertz, Simone
    Sikic, Danijel
    Denzinger, Stefan
    Burger, Maximilian
    Hartmann, Arndt
    Otto, Wolfgang
    CLINICAL GENITOURINARY CANCER, 2018, 16 (04) : 248 - +
  • [39] pT1 bladder cancer - Never ending story
    Stockle, M
    AKTUELLE UROLOGIE, 1997, 28 (05) : 237 - 238
  • [40] Mutations in TERT promoter and FGFR3 and telomere length in bladder cancer
    Hosen, Ismail
    Rachakonda, P. Sivaramakrishna
    Heidenreich, Barbara
    de Verdier, Petra J.
    Ryk, Charlotta
    Steineck, Gunnar
    Hemminki, Kari
    Kumar, Rajiv
    INTERNATIONAL JOURNAL OF CANCER, 2015, 137 (07) : 1621 - 1629
12345